Shows
CME in Minutes: Education in Primary CareLooking Ahead in Atopic Dermatitis: OX40/OX40L Mechanisms, Multidisciplinary Care, and Meaningful Patient OutcomesPlease visit answersincme.com/MRQ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alexandra K. Golant, MD; Peter Lio, MD, FAAD; and Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP. In this activity, experts in dermatology discuss the OX40L pathway and its potential role in the treatment of moderate-to-severe atopic dermatitis. Upon completion of this activity, participants should be better able to: Identify the rationale for targeting the OX40/OX40 ligand (OX40L) pathway in the treatment of moderate-to-severe atopic dermatitis (AD); Assess the evidence on efficacy outcomes and safety profiles of...
2026-06-2621 min
The Melanin Initiative's PodcastDermatology for Nurse Practitioners: How to Get Started, What to Study, and How to Build Confidence🚨 New Episode Alert! 🚨 🎙️Dermatology Nurse Practitioner career growth, dermatology NP certification, and how to transition into dermatology as a nurse or NP are exactly what this episode will help you understand. Are you feeling stuck in your career or unsure how to move into a specialty like dermatology? This episode is designed to give you clarity, confidence, and a real plan forward.🔥 In This Episode:This conversation is focused on helping you understand what it really takes to grow in your career as a nurse or nurse practitioner. If you have ever felt overwhelmed by career decisio...
2026-03-281h 12
THE DERMATOLOGY DIGEST DOWNLOADPrescribing Hope: The Podcast Episode 1: Of Patients and Patience in VitiligoIn this must-download episode of Prescribing Hope: The Podcast, Leigh Ann Pansch, MSN, FNP-BC, DCNP, the Clinical Director of Education at DOCS Dermatology in Cincinnati, OH, and Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Founder of Innovative Dermatology in Plano, TX, discuss the importance of managing your vitiligo patients' expectations about treatment and share how they counsel their patients.
2026-03-1707 min
The Dermalorian PodcastMOA FYI: Where Do Emerging AD and PsO Treatments Fit?There are potential new treatments emerging in 2026 for the treatment of atopic dermatitis and psoriasis. How do these treatments work and where will they fit into the treatment landscape? Jennifer Soung, MD gives an overview. Plus, Andrea Nguyen, DMSc, MPAS, PA-C provides an update on CSU treatment and Sandri Johnson, MSN, FNP-BC, DCNP and Alexa Hetzel, DMSc, PA-C celebrate the popularity of the dermatology specialty.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
2026-01-2817 min
OncTimes TalkThe Current State of Skin Cancer in the U.S.In this episode of OncTimes Talk, Dr. Victor Czerkasij, DNP, DCNP, FNP-C, CWCP, MSN, MA discusses the current state of skin cancer in the U.S.
2025-12-0135 minCME in Minutes: Education in Primary CareTerry Faleye, MPAS, PA-C / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing CarePlease visit answersincme.com/860/100752367-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of psoriatic disease discuss challenges in treatment, emerging TYK2 inhibitor therapies, and evidence-based strategies to optimize patient care. Upon completion of this activity, participants should be better able to: Recognize how nurse practitioners and physician associates can help address barriers to care and enhance outcomes for patients with moderate to severe plaque psoriasis; Differentiate TYK2 signaling from JAK pathways and explain the relevance of these distinctions in clinical outcomes; Evaluate the impact of emerging...
2025-11-201h 14
CME in Minutes: Education in DermatologyTerry Faleye, MPAS, PA-C / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Beyond Biologics for Psoriasis and PsA: TYK2 Inhibitors and Practical Considerations for Personalizing CarePlease visit answersincme.com/860/100752367-replay to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in the management of psoriatic disease discuss challenges in treatment, emerging TYK2 inhibitor therapies, and evidence-based strategies to optimize patient care. Upon completion of this activity, participants should be better able to: Recognize how nurse practitioners and physician associates can help address barriers to care and enhance outcomes for patients with moderate to severe plaque psoriasis; Differentiate TYK2 signaling from JAK pathways and explain the relevance of these distinctions in clinical outcomes; Evaluate the impact of emerging...
2025-11-201h 14
The Green Room: A Podcast from Obstetrics & GynecologyPrior Authorizations: Tips and Tricks In this episode of The Nurse Practitioner Podcast, Victor Czerkasij, DNP, DCNP, FNP-C, CWCP, MSN, MA discusses prior authorizations.
2025-10-1731 min
The Nurse Practitioner PodcastPrior Authorizations: Tips and TricksIn this episode of The Nurse Practitioner Podcast, Victor Czerkasij, DNP, DCNP, FNP-C, CWCP, MSN, MA discusses prior authorizations.
2025-10-1731 minCME in Minutes: Education in Primary CareApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2Please visit answersincme.com/JCY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in dermatology discuss the current and potential clinical impact of TYK2 inhibitors. Upon completion of this activity, participants should be better able to: Contrast the clinical implications of selective TYK2 inhibition versus pan-JAK inhibition in the treatment of moderate-to-severe plaque psoriasis; Interpret the clinical evidence for next-generation TYK2 inhibitors in patients with moderate-to-severe plaque psoriasis; and Integrate TYK2 inhibitors into clinical practice as they become available for patients with moderate-to-severe plaque psoriasis.
2025-08-0555 minCME in Minutes: Education in DermatologyApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Next-Generation Treatments for Moderate-to-Severe Plaque Psoriasis: What's New in TYK2Please visit answersincme.com/JCY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, experts in dermatology discuss the current and potential clinical impact of TYK2 inhibitors. Upon completion of this activity, participants should be better able to: Contrast the clinical implications of selective TYK2 inhibition versus pan-JAK inhibition in the treatment of moderate-to-severe plaque psoriasis; Interpret the clinical evidence for next-generation TYK2 inhibitors in patients with moderate-to-severe plaque psoriasis; and Integrate TYK2 inhibitors into clinical practice as they become available for patients with moderate-to-severe plaque psoriasis.
2025-08-0555 min
For The RecordEpisode 106: Laser-Focused: Raising the Bar with Energy Devices with Roni Bolton, APRN, DCNPWhat happens when "missteps" become milestones? In this electrifying episode, host Dr. Tiphany Hall sits down with Roni Bolton, APRN, DCNP—dermatology-certified nurse practitioner, laser trailblazer, and triple-threat CEO—to unpack how she turned clinical missteps into a career-defining empire.From launching her first practice to bring a device to market, and lending her expertise to a national laser brand, Roni’s journey is anything but ordinary. She didn’t set out to become “the laser queen"—but when patients with complex cases and darker skin tones came her way, she owned the challenge and created a space no one...
2025-07-251h 02
Optimized HealthEp. 41 Midlife Mane: Tackling Hair Loss With ConfidenceJoin Mandy Livingston and Laura Chastain as local expert, Emily Brewer, DCNP, and owner of The Derm Center, explore the primary causes of midlife hair thinning, including hormonal imbalances like menopause, nutritional deficiencies, and medical conditions. We willalso dive into treatment options ranging from topical solutions and supplements to lifestyle adjustments and advanced therapies, helping you navigate the journey to healthier, fuller hair.
2025-01-1436 min
Business on Top with Kaeli LindholmEpisode 248: Building a Cult Following: Lessons in Leadership and Scaling up with Allie McAllister, NP-C, DCNPIn this episode of The Fierce Factor, I'm joined by the extraordinary Allie McAllister—nurse practitioner, entrepreneur, and co-founder of Cult Aesthetics, Cult Conference, and Squeeze Skin. From her start at a cadaver lab in 2020 to leading three thriving businesses in the aesthetics industry, Allie's journey is nothing short of inspiring. Together, we explore what it takes to grow and scale with intention, all while maintaining integrity in your brand and practice. Allie candidly shares the triumphs and challenges of her first year as a business owner, touching on key topics like: Team building: Cultivating strong dy...
2025-01-131h 00
THE DERMATOLOGY DIGEST DOWNLOADExpert Perspectives: Itching for ReliefSpecial Bonus Podcast Episode
Featuring: Leigh Ann Pansch, MSN, FNP-BC, DCNP Shanna M. Miranti, MPAS, PA-C
2024-10-0812 min
PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 05
PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 04
PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 05
PeerView Clinical Pharmacology CME/CNE/CPE VideoApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 04
PeerView Internal Medicine CME/CNE/CPE Audio PodcastApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 05
PeerView Internal Medicine CME/CNE/CPE Video PodcastApril W. Armstrong, MD, MPH / Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World PracticeThis content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HBV865. CME/MOC/NCPD/AAPA/IPCE credit will be available until November 12, 2024.Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK2 as a Therapeutic Target in Real-World Practice In support of improving patient care, PVI, PeerView Institute for Medical Education...
2023-11-251h 04PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 min
PeerView Immunology & Transplantation CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minPeerView Internal Medicine CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minPeerView Clinical Pharmacology CME/CNE/CPE VideoLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 min
PeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP / Peter A. Lio, MD - Targeting Interleukins to Improve Treatment Outcomes in Atopic DermatitisGo online to PeerView.com/FRX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Atopic dermatitis (AD) is a chronic disease that affects a significant portion of the US population. The current treatment paradigm for AD is complex, involving multiple active drugs tailored to different body parts, stages of the disease, and severity levels, in addition to moisturizers, bathing practices, and lifestyle recommendations. However, the effectiveness of certain available treatment options is limited because of concerns regarding efficacy, tolerability, and safety. In recent years, there have been significant advancements in the treatment...
2023-09-2133 minThe Dermalorian PodcastSame Difference: Biosimilars in DermatologyThe first self-administered biosimilars for dermatology have come to market, bringing along a number of questions for patients, prescribers, pharmacists, and others. TJ Chao, MPAS, PA-C and Leigh Ann Pansch, MSN, FNP-BC, DCNP break through the noise to explain biosimilars, interchangeability, and implications for patient care. Plus, hear from Hilary Baldwin, MD, about giving great presentations and Adam Friedman, MD sweats the details of hyperhidrosis diagnosis.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
2023-08-2926 min
Learn Skin with Dr. Raja and Dr. HadarEpisode 161: AestheticsThink skin aesthetics are the same old thing? Think again. This week, we're joined by Allie McAllister, founder of The Atlanta Injector, as she walks us through the importance of training, the growing demand for aesthetics, and just how much aesthetics have evolved over the past ten years. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Allie McAllister, NP-C DCNP is a Dermatology Certified Nurse Practitioner specializing in anti-aging aesthetics, and the founder...
2023-08-1023 minThe Dermalorian PodcastA Sneak Peek at DERM2023What's coming up at DERM2023 StrangerDx? Listen in as DEF Founder, Joe Gorelick, MSN, FNP-C; Andrea Nguyen, MS, PA-C; Adam Friedman, MD; Michelle Hure, MD; Ted Rosen, MD; and Leigh Ann Pansch, MSN, FNP-BC, DCNP, give updates about the CME conference and share previews from their presentations. Get insights on STD incidence and prevention, "forever chemicals" in dermatology, and unusual presentations that may or may not be associated with COVID-19 vaccination.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
2023-07-1912 min
The Dermalorian PodcastTools of the Dermatology TradeWhat clinical tools can't you live without? In this episode, Joe Gorelick, MSN-FNP-C, Leigh Ann Pansch, MSN, FNP-BC, DCNP, and Darren West, MPAS, PA discuss the tools they use nearly every day. Plus, Ted Rosen, MD, FAAD, provides an update on heat for molluscum and David Cohen, MD addresses the use of biologics in the peri-surgical period.Like what you're hearing? Want to learn more about the Dermatology Education Foundation? Explore assets and resources on our website.
2023-04-0421 minPeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Clinical Pharmacology CME/CNE/CPE VideoLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Internal Medicine CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Immunology & Transplantation CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 minPeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - Taking a Team-Based Approach to Moderate to Severe Psoriasis in an Era of Expanding Oral Treatment Options: Advanced Practice Clinicians as Key Partners in CareGo online to PeerView.com/WCP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Psoriasis is a widely prevalent, chronic, systemic, immune-mediated disease that substantially impairs patients’ physical health, quality of life and work productivity. Nearly one-quarter of people with psoriasis have cases that are considered moderate to severe. Despite the availability of effective systemic therapy, many patients remain undertreated or even untreated and are dissatisfied with current treatments. In this activity, two experts review the rationale for TYK2 inhibition as a novel approach for the treatment of moderate to severe psoriasis. In...
2023-03-3039 min
The Success NP: Clinical Pearls for Nurse PractitionersDNP Ep. 55: The Journey of the Dermatology NP CoachThis week we hear from Patricia Delgado who graduated with her BSN in 2010 and worked in critical care for five years before becoming a nurse practitioner in outpatient dermatology care. Patricia has found her calling in helping each unique individual navigate their path towards better health and overall wellbeing. She believes ALL nurses deserve to feel fulfilled in their careers and loves to help connect others to their dream jobs. She is passionate about helping others see and focus on their inner potential in their careers and in their lives. She offers career coaching and mentorship, in addition for...
2022-08-2241 minPeerView Internal Medicine CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 02PeerView Clinical Pharmacology CME/CNE/CPE VideoLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 03PeerView Family Medicine & General Practice CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 02PeerView Family Medicine & General Practice CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 03PeerView Clinical Pharmacology CME/CNE/CPE Audio PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 02PeerView Internal Medicine CME/CNE/CPE Video PodcastLakshi Aldredge, MSN, ANP-BC, DCNP, FAANP - The Power of Team-Based Care and Novel Therapies in Alopecia Areata and Atopic Dermatitis: What Advanced Care Providers Need to KnowGo online to PeerView.com/REA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Listen to our expert faculty as they discuss new and emerging therapies for AA and AD, with a focus on mechanisms of action, efficacy and safety profiles, nuances of administration and use, and risk:benefit profile. You will also hear about novel therapies in late-stage development for the treatment of moderate to severe AD and AA. The Late Night inExchange format is designed to meet the educational needs of clinicians with practice-relevant education presented in an engaging multi-faculty...
2022-08-031h 03
Decera Clinical Education APP PodcastManagement of Atopic Dermatitis in Primary Care and Specialty SettingsThis podcast episode is part of a multimedia program discussing the co-management of moderate to severe atopic dermatitis (AD) in the primary care and specialty settings. Tune in to hear Dr Silverberg and NP Victoria Garcia-Albea highlight newly approved agents and the recent expanded labeling of an existing AD therapy, including:Â Ruxolitinib, a topical JAK inhibitor for mild to moderate AD approved in 2021Â Abrocitinib and upadacitinib, oral JAK inhibitors approved in early 2022 for moderate to severe ADTralokinumab, an IL-13 inhibitor available as a subcutaneous injection, which was approved in late 2021 for moderate to severe ADExpanded approval for use in...
2022-07-1920 min
Clinical Appraisal69. Carving a clinical research path as a DNP (feat. Dr. Patricia M. Delgado)In this episode, Ian speaks with Dr. Patricia M. Delgado, DNP, APRN, DCNP. Patricia is a DNP-prepared principal investigator with extensive training in adult-gerontological primary care and subspecialty training in dermatology about her journey into clinical research, what hurdles she overcame to be afforded the opportunity to be a PI, and her perspective on the viability of this path for others with similar training. Her interests in the intersection of psychiatric and dermatological research was also discussed, from the perspective of there being unique and important questions to answer from her vantage point as a DNP-prepared clinical researcher.
2021-12-3023 min
Health XPlainedTreatment and Prevention of Sprains and StrainsIn this episode, Next Level Provider Lead, Steve Mack, DCNP explains the difference between sprains and strains, at home treatment, and when to seek out medical care.
2021-06-0813 min
Health XPlainedCommunication Amongst Providers and PatientsIn this episode, Next Level Urgent Care Provider Lead, Steve Mack, DCNP talks about the importance of communicating well with patients for medical providers and offers suggestions to patients who need clarification on a diagnosis.
2021-03-2311 min
WOCTalkBonus EP 15: Diagnosis and Management of Parastomal AbscessesDuring this special bonus WOCTalk episode, we sit down with Virginia (Ginny) Hanchett, FNP, APRN-BC, DCNP, COCN, CWCN, to discuss content related to a recent webinar, “Parastomal Abscesses: Exploring the Differential Diagnoses and Treatment Options”. Ginny elaborates on the different pathologies and diagnoses of parastomal abscesses, underlying causes, and prevention and treatment options.This podcast and the original webinar were supported by Hollister Incorporated. The WOCN Society does not endorse specific products or services.Episode ResourcesClick here to view the recording of the webinar, “Parastomal Abscesses: Exploring the Differential Diagnoses and Treatment Option...
2021-02-0237 min
I AM HUMAN139: Vegan Skin Care and Cosmetics with Kari Knight DCNP (Veggie Doctor Radio)In this episode of Veggie Doctor Radio, I chat with Kari Knight, DCNP about vegan skin care and cosmetics. About featured guest:Kari was mostly vegetarian most of her life. She integrated a whole food plant-based diet for health reasons, but then her heart opened up to the ethical and compassionate reasons for veganism. Still early on in her journey, she is learning and exploring. Because she is a passionate dermatology nurse practitioner, I reached out to Kari to help me understand more about vegan skin care as cosmetics so that I could b...
2021-01-171h 09
The Tea with Auric BSPF AFMay is skin cancer awareness month which means you should do exactly what that title says and listen to this truth dropping episode of Tea Time! Dermatology expert Catie Boucher, FNP-C, DCNP, joins Josh this week to talk all about the stupid things they used to do to their skin back in the day to be tan. Double 30 minute baking appointments at the tanning salon seemed like a great idea at the time right?! BUT THAT PLAYBOY BUNNY STICKER WAS SOOO CUTE! (Insert massive eye roll) But now they have both become human cutting boards for skin cancer removal...that...
2020-05-261h 08WOCTalkBonus EP 9: Dermostomy: Advanced Dermatological Conditions of the Parastomal RegionOn this bonus episode of WOCTalk we sit down with Virginia Hanchett, FNP, APRN-BC, DCNP, COCN, CWCN, a Program Director and Senior Nurse Practitioner at “UR Medicine Ostomy Services” at the University Of Rochester Medical Center in Rochester, New York. She has 20 years of experience in the field of Wound, Ostomy and Continence Nursing and 15 years experience in medical dermatology. She has been proudly employed at the University of Rochester Medical Center for over 30 years and for the past 5 years she has focused on the well being of ostomy patients throughout the continuum of care, with long-term management being her l...
2020-03-2728 min
Across the Airwaves Podcast (Network Archive)DC Nation Podcast Week 55 - "Whatever Happened with Dan Reviewing Man of Steel?"EXTRA! EXTRA! THE OFFICIAL DC NATION PODCAST COVERAGE OF "MAN OF STEEL" IS ONLINE!
ALSO, SPOILERS!!!!
That's right folks, look, up in the sky, it's not a bird, not a plane, it's Across the Airwaves' DC Nation Podcast, your #1 source for coverage on DC Entertainment's animation, comics, films, and much more! On this week's edition of the DCNP, Dan & Michael cover DC Comics' latest blockbuster after last year's fantastic film The Dark Knight Rises - and that film is: MAN OF STEEL! Now, Man of Steel is ATA's most anticipated film of the summer, and...
2013-06-241h 41
Across the Airwaves Podcast (Standard MP3)DC Nation Podcast Week 55 (Standard) "What Ever Happened with Dan Reviewing Man of Steel?"
EXTRA! EXTRA! THE OFFICIAL DC NATION PODCAST COVERAGE OF "MAN OF STEEL" IS ONLINE!
ALSO, SPOILERS!!!!
That's right folks, look, up in the sky, it's not a bird, not a plane, it's Across the Airwaves' DC Nation Podcast, your #1 source for coverage on DC Entertainment's animation, comics, films, and much more! On this week's edition of the DCNP, Dan & Michael cover DC Comics' latest blockbuster after last years fantastic film The Dark Knight Rises - and that film is: MAN OF STEEL! Now, Man of Steel is ATA's most anticipated film of the...
2013-06-231h 41
Across the Airwaves Podcast (Network Archive)DC Nation Podcast Week 55 (Standard) "What Ever Happened with Dan Reviewing Man of Steel?"
EXTRA! EXTRA! THE OFFICIAL DC NATION PODCAST COVERAGE OF "MAN OF STEEL" IS ONLINE!
ALSO, SPOILERS!!!!
That's right folks, look, up in the sky, it's not a bird, not a plane, it's Across the Airwaves' DC Nation Podcast, your #1 source for coverage on DC Entertainment's animation, comics, films, and much more! On this week's edition of the DCNP, Dan & Michael cover DC Comics' latest blockbuster after last years fantastic film The Dark Knight Rises - and that film is: MAN OF STEEL! Now, Man of Steel is ATA's most anticipated film of the...
2013-06-231h 41Across the Airwaves Podcast (Standard MP3)DC Nation Podcast Week 29 (Standard) “Gamma Rays Will Not Give You Super Powders”
Hello DC Nationites and welcome back to Across the Airwaves' very own (and so far only) DC Nation Podcast!!! On this week's episode of DCNP, Dan and I cover the returns of two of our favorite shows to watch (and review): Green Lantern: The Animated Series and Young Justice: Invasion! The Green Lantern episode "The New Guy" was great as it introduced new GL of Sector 2814 "Guy Gardner" as well as the new villain for the second half of the season, and of course, setting up Hal's role in the coming Crisis. We even get our friend...
2012-10-051h 54
Across the Airwaves Podcast (Network Archive)DC Nation Podcast Week 29 (Standard) “Gamma Rays Will Not Give You Super Powders”
Hello DC Nationites and welcome back to Across the Airwaves' very own (and so far only) DC Nation Podcast!!! On this week's episode of DCNP, Dan and I cover the returns of two of our favorite shows to watch (and review): Green Lantern: The Animated Series and Young Justice: Invasion! The Green Lantern episode "The New Guy" was great as it introduced new GL of Sector 2814 "Guy Gardner" as well as the new villain for the second half of the season, and of course, setting up Hal's role in the coming Crisis. We even get our friend...
2012-10-051h 54